Contract Research Organization (CROs) Services Market worth $86.5 billion by 2026 - Exclusive Report by MarketsandMarkets™
CHICAGO, July 19, 2021 /PRNewswire/ -- According to the new market research report "Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Laboratory), Therapeutic Area (Oncology, Infectious Disease), Molecule Type (Vaccine, CGT), End User (Pharma, Biopharma, Research Institute) - Global Forecast to 2026", published by MarketsandMarkets™, the global CRO Services Market is projected to reach USD 86.5 billion by 2026 from USD 53.2 billion in 2021, at a CAGR of 10.7% during the forecast period.
Browse in-depth TOC on "Contract Research Organization (CROs) Services Market"
431 – Tables
64 – Figures
389 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167410116
The Growth in the CRO Services Market can mainly be attributed to factors such as increasing investment in pharmaceutical R&D to drive CROs services market, increasing number of clinical trials, high cost of in-house drug development and rising prevalence of orphan and rare diseases. On the other hand, shortage of skilled professionals and meeting the need of providing unique analytical testing approach may challenge market growth to a certain extent.
Clinical research services segment accounted for the largest share of contract research organization (CRO) services market
On the basis of type, the market is segmented into early-phase services, clinical research services, laboratory services, and consulting services. The clinical research services segment dominated the market in 2020. The large share of this segment can be attributed to rapid growth in the geriatric population, subsequent increase in the prevalence of chronic diseases, rising demand for newer drugs, and increasing product development of new drugs. The data management services segment is expected to register the highest CAGR during the forecast period due to need for generation of high-quality data & its management and rising importance data handling.
Oncology segment accounted for the largest share of the contract research organization (CRO) services market
Based on therapeutic area, the global CRO services market is broadly categorized into oncology, infectious diseases, neurology, cardiovascular system (CVS) disorders metabolic disorders/endocrinology, immunological disorders, respiratory disorders, psychiatry, dermatology, hematology, ophthalmology, gastrointestinal diseases, genitourinary & women's health, and other therapeutic areas. The oncology segment is the largest segment in the market. Growth of the segment is attributed to the high incidence of cancer and pipeline of drugs in late-stage development.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=167410116
Cell and gene therapy segment is projected to register the highest CAGR during the forecast period
Based on molecule type, the global CRO services market is segmented into vaccines, cell & gene therapy and other molecules. The cell & gene therapy segment is expected to register the highest CAGR during the forecast period owing to promising therapies in pipeline and rising R&D expenditure in regenerative medicine.
Pharmaceutical & biopharmaceutical companies segment accounted for the largest share of contract research organization (CRO) services market
Based on end user, the global market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. In 2020, the pharmaceutical & biopharmaceutical companies segment dominated the market owing to increased outsourcing of early-phase development services and clinical and laboratory testing services by pharmaceutical companies.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=167410116
North America accounted for the largest share of the contract research organization (CRO) services market
The contract research organization services market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). In 2020, North America accounted for the largest share of the CRO Services Market, followed by Europe. The large share of the North American regional segment can be attributed to presence of a well-established base of pharmaceutical & biopharmaceutical companies, and high investments in the biosimilars & biologics segment.
The prominent players operating in the contract research organization (CRO) services market are IQVIA (US), LabCorp (US), Charles River Laboratories (US), WuXi AppTec (China), Syneos Health (US), PPD (US), and ICON Plc (US).
Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting
Browse Related Reports:
Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-services-market-138732129.html
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) - Global Forecast 2026
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/contract-research-organization-service-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/contract-research-organization-service.asp
SOURCE MarketsandMarkets
Share this article